Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...

By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...

A new brain-computer interface can decode a person's inner speech, which could help people with paralysis communicate.

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...

Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...

"MTPA’s Radicava shows long-term benefit in ALS trials" was originally created and published by Clinical Trials Arena, a ...

Stanford University scientists have developed a brain implant designed to "hear" and vocalize words a person with severe ...

Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.

• Key Amyotrophic Lateral Sclerosis Pipeline Therapies: ION363, FB418, SRK-015, RNS60, QRL-201, SAR443820, MN-166, VM202, VRG-50635, Zilucoplan, and others.

Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease, with an incidence of 1 or 2 cases per 100,000 persons and a lifetime risk of 1 case per 800 persons.

Correspondence Amyotrophic Lateral Sclerosis Published October 11, 2001 N Engl J Med 2001;345: 1131 - 1132 DOI: 10.1056/NEJM200110113451514 ...